The Lausanne University Hospital, in Lausanne, is one of the five university hospitals in Switzerland. The Lausanne University Hospital is linked to the Faculty of Biology and Medicine of the University of Lausanne. The CHUV's medical services benefit over 45,000 patients a year.

There are 1,568 beds in CHUV Lausanne.

During the past decade, CHUV Lausanne conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHUV Lausanne" #1 sponsor was "Centre Hospitalier Universitaire Vaudois" with 5 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored, "University Hospital Inselspital, Berne" with 3 trials sponsored, "PTC Therapeutics" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHUV Lausanne" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Swiss Group for Clinical Cancer Research" with 2 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "CHUV Lausanne" are "Acute Myeloid Leukemia" (3 trials), "Articular Cartilage Defect" (2 trials), "Chondral Defect" (2 trials), "Genetic Diseases, Inborn" (2 trials) and "Genetic Diseases, X-Linked" (2 trials). Many other conditions were trialed in "CHUV Lausanne" in a lesser frequency.

Most popular intervention types in "CHUV Lausanne" are "Drug" (13 trials), "Device" (6 trials), "Other" (5 trials), "Procedure" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ataluren" (2 trials), "Midostaurin" (2 trials), "1.25 g PA21 (250 mg iron)" (1 trials) and "10.0 g PA21 (2,000 mg iron)" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHUV Lausanne" are 27 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 14 active trials in "CHUV Lausanne". 1 are not yet recruiting, 11 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in CHUV Lausanne, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in CHUV Lausanne, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".

CHUV Lausanne has several departments that took part in Clinical trials: "CHUV; Departement d'Oncologie" - 27 trials, "Department of Visceral Surgery, University Hospital Center" - 9 trials, "Department of Anesthesia, Centre Hospitalier Universitaire Vaudois and University of Lausanne" - 5 trials, "Service de Néphrologie" - 4 trials, "Division of Clinical Pharmacology, Centre Hospitalier Universitaire Vaudois (CHUV)" - 2 trials, "Département de l'Appareil Locomoteur - CHUV" - 6 trials, "CHUV Département femme-mère-enfant" - 2 trials, "Department of Psychiatry-CHUV, University of Lausanne" - 2 trials, "CHUV - Hopital Orthopedique" - 2 trials, "Division of Clinical Pharmacology" - 2 trials, "(CHUV), Centre Hospitalier Universitaire Vaudois - Departement des Neurosciences Cliniques" - 2 trials, "Fondation du centre Pluridisciplinaire d'Oncologie (CePO)" - 2 trials, "Department Women, Mother & Child, University Hospital" - 2 trials